Page last updated: 2024-11-08

coumestan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

coumestan: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

coumestan : A member of the class of coumestans that is 6H-[1]benzofuro[3,2-c]chromene substituted by an oxo group at position 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID638309
CHEBI ID72578
SCHEMBL ID15864245
MeSH IDM0492553

Synonyms (15)

Synonym
6h-[1]benzofuro[3,2-c]chromen-6-one
inchi=1/c15h8o3/c16-15-13-9-5-1-3-7-11(9)17-14(13)10-6-2-4-8-12(10)18-15/h1-8
6h-benzofuro[3,2-c][1]benzopyran-6-one
benzofurano(3',2':3,4)coumarin
coumestan
unii-mt103z562v
mt103z562v ,
(1)benzoxolo(3,2-c)chromen-6-one
6h-benzofuro(3,2-c)(1)benzopyran-6-one
[1]benzoxolo[3,2-c]chromen-6-one
479-12-9
CHEBI:72578
SCHEMBL15864245
DTXSID30197316
Q2608767

Research Excerpts

Overview

Coumestan wedelolactone is an important phytocomponent from Eclipta alba (L.) Hassk. It is a natural tetracycle with a C═C bond shared by a coumarin moiety and a benzofuran moiety.

ExcerptReferenceRelevance
"Coumestan wedelolactone is an important phytocomponent from Eclipta alba (L.) Hassk. "( Optimization of sample preparation variables for wedelolactone from Eclipta alba using Box-Behnken experimental design followed by HPLC identification.
Patil, AA; Sachin, BS; Shinde, DB; Wakte, PS, 2013
)
1.83
"Coumestan is a natural tetracycle with a C═C bond shared by a coumarin moiety and a benzofuran moiety. "( Coumestan inhibits radical-induced oxidation of DNA: is hydroxyl a necessary functional group?
Liu, ZQ; Xi, GL, 2014
)
3.29

Treatment

ExcerptReferenceRelevance
"Coumestan-treated groups showed a significant decrease in the oocyst counting since the 21 th day of life and displayed a reduced number of macroscopic lesions."( Anticoccidial effects of coumestans from Eclipta alba for sustainable control of Eimeria tenella parasitosis in poultry production.
Bertolini, LC; Esteves, AF; Franca, SC; Michels, MG; Moreira, P, 2011
)
1.39

Bioavailability

ExcerptReferenceRelevance
"The extensive glucuronidation and methylation is responsible for the low oral bioavailability of WEL in rats."( Wedelolactone metabolism in rats through regioselective glucuronidation catalyzed by uridine diphosphate-glucuronosyltransferases 1As (UGT1As).
Chen, XY; Huang, XJ; Li, L; Peng, JL; Zhang, CF; Zheng, MY; Zhong, DF, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
phytoestrogenAny compound produced by a plant that happens to have estrogenic activity.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
coumestansMembers of the class of benzofurochromene with a 6H-[1]benzofuro[3,2-c]chromene skeleton and its substituted derivatives. They are the 3,4-didehydroderivatives of pterocarpans.
delta-lactoneA lactone having a six-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (22.00)29.6817
2010's30 (60.00)24.3611
2020's9 (18.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.66 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.92%)5.53%
Reviews6 (11.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (86.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]